These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24858206)

  • 1. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
    Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
    Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
    Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).
    Semaan A; Qazi AM; Seward S; Chamala S; Bryant CS; Kumar S; Morris R; Steffes CP; Bouwman DL; Munkarah AR; Weaver DW; Gruber SA; Batchu RB
    Pharm Res; 2011 Dec; 28(12):3079-90. PubMed ID: 21818714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.
    Wu GQ; Xie D; Yang GF; Liao YJ; Mai SJ; Deng HX; Sze J; Guan XY; Zeng YX; Lin MC; Kung HF
    Int J Cancer; 2009 Dec; 125(11):2631-42. PubMed ID: 19672860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β-catenin signaling pathway.
    Zhang X; Liu R; Zhao N; Ji S; Hao C; Cui W; Zhang R; Hao J
    Mol Carcinog; 2019 Jun; 58(6):1008-1018. PubMed ID: 30720232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes.
    Chen Y; Mu X; Wang S; Zhao L; Wu Y; Li J; Li M
    Oncol Rep; 2013 Jan; 29(1):288-96. PubMed ID: 23129262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.
    Zhang H; Hao C; Wang Y; Ji S; Zhang X; Zhang W; Zhao Q; Sun J; Hao J
    Mol Carcinog; 2016 Jul; 55(7):1127-37. PubMed ID: 26153894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
    Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
    Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
    Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
    Teng Y; Zhang Y; Qu K; Yang X; Fu J; Chen W; Li X
    Oncotarget; 2015 Dec; 6(38):40799-814. PubMed ID: 26512921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
    Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
    Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Li J; Huang H; Li Y; Li L; Hou W; You Z
    Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.